A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(36 sites)

Canada

Local Institution - 0008, Halifax, Nova Scotia

China

Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, GD

Nanfang Hospital of Southern Medical University, Guangzhou, GD

The First People's Hospital of Foshan, Foshan, Guangdong

Maoming People's Hospital, Maoming Shi, Guangdong